ABCC3 and central nervous system cancer: However, the subgroup analysis according to the glioma pathology type showed that the overall survival of patients with astrocytoma and oligoastrocytoma with high expression of ABCC3 was significantly lower than that of patients with high expression of ABCC3 (P<0.05), but there was no significant difference in disease progression survival (P> 0.05).